Whalegun
Home

Jonathan Zalevsky, Chief R&D Officer: Nektar Therapeutics NKTR Sell · Filed 25/09/08

Trade details

Type
Insider sale
Amount
$25,716.99
Shares · price
793 sh · $32.43 a share
Held after
18,390 sh
Stock
Nektar Therapeutics NKTR
Person
Jonathan ZalevskyChief R&D Officer
Trade date
25/09/04
Filed
25/09/08
Days to filing
4 days

Sold 4.1% of holdings

Share of holding sold
4.1%

Nektar Therapeutics trades, last 26 weeks

What else happened in Nektar Therapeutics around then

Filed or reported within 30 days of the trade day · 25/08/05~25/10/04

Jonathan Zalevsky's recent trades

  • Jonathan Zalevsky

    Planned saleNektar Therapeutics

    $13.4K

    Filed 08/18

  • Jonathan Zalevsky

    Planned sale10b5-1 planNektar Therapeutics

    $371.5K

    Filed 06/30

  • Jonathan Zalevsky

    Sell10b5-1 planNektar Therapeutics

    $336.2K

    Filed 06/17

  • Jonathan Zalevsky

    Planned sale10b5-1 planNektar Therapeutics

    $328.8K

    Filed 06/15

  • Jonathan Zalevsky

    SellNektar Therapeutics

    $13K

    Filed 05/21

Jonathan Zalevsky, Chief Officer — sold $25.7K of Nektar Therapeutics NKTR · 4.1% of holdings · 10b5-1 plan | Whalegun